Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 640 participants.

Also called NCT05367037

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 640 participants (planned count) (from the registry)
Sponsor
Quovadis Associazione (from the registry)
Registry
  • NCT NCT05367037
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05367037. Randomized; triple masking; primary purpose prevention. Start 2022-07-27 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval
Acronym
PhysioVP-AF
Condition
Sinus Node Disease
Condition
Atrioventricular; Block, Second Degree (Types I and II)
Intervention (Device)
PhysioVP
Intervention (Device)
DDD-VPA
Lead sponsor
Quovadis Associazione (class: other)

Record details

Record id
cardio:ct-nct05367037
Content hash
348ee09f82157490b185d8d15a948ff7dd5ee6e0398034c0a78694cfe20ab6d3